Derek T. Chalmers, President & CEO at Cara Therapeutics, Inc. (CARA), sold 6,206 shares at $17.98 ($112K) on 2021-03-05, disclosed to the SEC on 2021-03-08.
Open-market sale of $112k CARA by President & CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $17.98 | 3,103 | $56K | 50.0% |
| 2 | $17.98 | 3,103 | $56K | 50.0% |
| Total | $17.98 avg | 6,206 | $112K | 100% |
| Filing → |
| CARA | SELL | 2021-02-25 | $453K | — | Filing → |
| CARA | SELL | 2020-12-30 | $186K | — | Filing → |
| CARA | SELL | 2020-12-29 | $80K | — | Filing → |